Related references
Note: Only part of the references are listed.Increased Urinary Excretion of 3-Methoxytyramine in Patients with Head and Neck Paragangliomas
N. van Duinen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Brief Communication: Radiographic Contrast Infusion and Catecholamine Release in Patients With Pheochromocytoma
Smita K. Baid et al.
ANNALS OF INTERNAL MEDICINE (2009)
Phase II Study of Safety and Efficacy of Motesanib in Patients With Progressive or Symptomatic, Advanced or Metastatic Medullary Thyroid Cancer
Martin J. Schlumberger et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells
David Yu Greenblatt et al.
ANNALS OF SURGERY (2008)
Suberoyl bishydroxamic acid activates Notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma
Li Ning et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas:: CT and MRI correlation
Kunwar S. S. Bhatia et al.
CLINICAL ENDOCRINOLOGY (2008)
Motesanib diphosphate in progressive differentiated thyroid cancer
Steven I. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Current management of medullary thyroid cancer
Rebecca S. Sippel et al.
ONCOLOGIST (2008)
131I-MIBG Therapy in metastatic phaeochromocytoma and paraganglioma
Gonca Kara Gedik et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Approach to the patient - Preoperative management of the pheochromocytoma patient
Karel Pacak
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
The effects of carbidopa on uptake of 6-18F-fluoro-L-DOPA in PET of pheochromocytorna and extraadrenal abdominal paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Increased risk of lymph node metastasis in multifocal hereditary and sporadic medullary thyroid cancer
Andreas Machens et al.
WORLD JOURNAL OF SURGERY (2007)
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma
I. S. Mackenzie et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
J. W. B. de Groot et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients
M. R. Pelizzo et al.
EJSO (2007)
Initial lymph node dissection increases cure rates in patients with medullary thyroid cancer
David Yue Greenblatt et al.
ASIAN JOURNAL OF SURGERY (2007)
Inactivation of glycogen synthase kinase-3β, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Pheochromocytoma: recommendations for clinical practice from the First International Symposium
Karel Pacak et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Is supine rest necessary before blood sampling for plasma metanephrines?
Jacques W. M. Lenders et al.
CLINICAL CHEMISTRY (2007)
Radioguided parathyroidectomy in patients with familial hyperparathyroidism
Alysandra Lal et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Medullary thyroid cancer: therapeutic targets and molecular markers
Douglas W. Ball
CURRENT OPINION IN ONCOLOGY (2007)
Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma
Henri J. L. M. Timmers et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Pheochromocytoma as a catecholamine producing tumor: Implications for clinical practice
T. Zelinka et al.
STRESS-THE INTERNATIONAL JOURNAL ON THE BIOLOGY OF STRESS (2007)
Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells
Muthusamy Kunnimalaiyaan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002
Muthusamy Kunnimalaiyaan et al.
SURGERY (2006)
High frequency of SDHB germline mutations in patients with malignant catecholamine-producing paragangliomas:: Implications for genetic testing
Frederieke M. Brouwers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Prognosis of medullary thyroid carcinoma - Demographic, clinical, and pathologic predictors of survival in 1252 cases
Sanziana Roman et al.
CANCER (2006)
Sensitivity and positive predictive value of CT, MRI and 123I-MIBG scintigraphy in localizing pheochromocytomas:: A prospective study
Franco Lumachi et al.
NUCLEAR MEDICINE COMMUNICATIONS (2006)
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes
DE Benn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Genetic testing in pheochromocytoma or functional paraganglioma
L Amar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma
J Barbet et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A
MA Skinner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells
JJ Van Gompel et al.
MOLECULAR CANCER THERAPEUTICS (2005)
RET proto-oncogene:: A review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors
MA Kouvaraki et al.
THYROID (2005)
Extent of disease and practice patterns for medullary thyroid cancer
E Kebebew et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor
EE Elder et al.
JOURNAL OF SURGICAL ONCOLOGY (2005)
Functional Imaging of endocrine tumors: Role of positron emission tomography
K Pacak et al.
ENDOCRINE REVIEWS (2004)
Hereditary medullary thyroid carcinoma in patients greater than 50 years old
FJ Quayle et al.
SURGERY (2004)
Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma
I Ilias et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Pheochromocytoma: The expanding genetic differential diagnosis
J Bryant et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Biochemical diagnosis of pheochromocytoma: How to distinguish true- from false-positive test results
G Eisenhofer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer
C Scollo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
A comparison of biochemical tests for pheochromocytoma: Measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines
AM Sawka et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The role of human achaete-scute homolog-1 in medullary thyroid cancer cells
RS Sippel et al.
SURGERY (2003)
Germ-line mutations in nonsyndromic pheochromocytoma.
HPH Neumann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Biochemical diagnosis of pheochromocytoma - Which test is best?
JWM Lenders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pheochromocytomas:: Detection with 18F DOPA whole-body PET -: Initial results
S Hoegerle et al.
RADIOLOGY (2002)
Multiple endocrine neoplasia type 2 and RET:: from neoplasia to neurogenesis
JR Hansford et al.
JOURNAL OF MEDICAL GENETICS (2000)
The perioperative management of children with phaeochromocytoma
HA Hack
PAEDIATRIC ANAESTHESIA (2000)
Share Paper
